HPRT and the Lesch—Nyhan syndrome
✍ Scribed by Pragna I. Patel; C. Thomas Caskey
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 638 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
✦ Synopsis
De$ciency of the enzyme hypoxanthineguanine phosphoribosyltransferase (HPRT) in humans leads to the neurological disorder, Lesch-Nyhan syndrome.
HPRTcDNA sequences have been used to demonstrate a heterogeneous group of mutations causing this disorder, one of which is clearly a new mutation. HPRT expression vectors, which function in conferring the H P R P phenotype to Lesch-Nyhan fibroblasts and lymphoblasts, have been constructed using cDNA sequences. Retroviruses encoding human HPRT have been used to infect bone marrow cells followed by transplantation of these cells into mice. The successful transfer and expression of the human HPRT gene in mice is a promising step towards somatic cell therapy for Lesch-Nyhan syndrome.
📜 SIMILAR VOLUMES
Metabolic studies in a case of Lesch-Nyhan syndrome are presented. De novo synthesis of purine was shown to be inhibited upon adenine administration. The excretion of oxypurines is elevated, however, by an increased incorporation of the administered adenine into purine bases. A side effect of adenin
## Abstract For Abstract see ChemInform Abstract in Full Text.